Concurrent B-cell acute lymphoblastic leukemia and plasma cell neoplasm with plasmablastic features supporting divergent evolution from a shared precursor: a case report - Top-Institutions - MDSpire

Concurrent B-cell acute lymphoblastic leukemia and plasma cell neoplasm with plasmablastic features supporting divergent evolution from a shared precursor: a case report

  • By

  • Antonija Babić

  • Ivana Franić Šimić

  • Josip Knežević

  • Koraljka Gjadrov Kuveždić

  • Ivana Ilić

  • Ida Ivek

  • Lara Divjak

  • Alojzija Brčić

  • Klara Bardač

  • Dora Višnjić

  • Radovan Vrhovac

  • Vilma Dembitz

  • Drago Batinić

  • Hrvoje Lalić

  • July 10, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Hematology
    • Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Hematology
    • Oncology

Original Source(s)

Concurrent B-cell acute lymphoblastic leukemia and plasma cell neoplasm with plasmablastic features supporting divergent evolution from a shared precursor: a case report

  • by Antonija Babić, Ivana Franić Šimić, Josip Knežević, Koraljka Gjadrov Kuveždić, Ivana Ilić, Ida Ivek, Lara Divjak, Alojzija Brčić, Klara Bardač, Dora Višnjić, Radovan Vrhovac, Vilma Dembitz, Drago Batinić, Hrvoje Lalić

  • July 10, 2026

Related Content

Risk stratification model based on estimated dose of radiation to immune cells and radiotherapy-related nadir lymphocyte count for predicting the efficacy of consolidation immunotherapy in stage III non-small cell lung cancer

Correction: DPCrossU-Net: a dual-branch parallel CNN–Transformer network for lung nodule segmentation

Beyond the dose-volume histogram: a critical appraisal of normal tissue complication probability modelling for osteoradionecrosis of the jaw and a strategic framework for clinical translation